Biodegradation-Mediated Enzymatic Activity-Tunable Molybdenum Oxide Nanourchins for Tumor-Specific Cascade Catalytic Therapy.
Journal
Journal of the American Chemical Society
ISSN: 1520-5126
Titre abrégé: J Am Chem Soc
Pays: United States
ID NLM: 7503056
Informations de publication
Date de publication:
22 01 2020
22 01 2020
Historique:
pubmed:
28
12
2019
medline:
26
1
2021
entrez:
28
12
2019
Statut:
ppublish
Résumé
Recent advances in nanomedicine have facilitated the development of potent nanomaterials with intrinsic enzyme-like activities (nanozymes) for cancer therapy. However, it remains a great challenge to fabricate smart nanozymes that precisely perform enzymatic activity in tumor microenvironment without inducing off-target toxicity to surrounding normal tissues. Herein, we report on designed fabrication of biodegradation-medicated enzymatic activity-tunable molybdenum oxide nanourchins (MoO
Identifiants
pubmed: 31880441
doi: 10.1021/jacs.9b13586
doi:
Substances chimiques
Oxides
0
Molybdenum
81AH48963U
Oxidoreductases
EC 1.-
Catalase
EC 1.11.1.6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM